Audited Results of Novartis India Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	354.33	356.27	335.07	378.74	399.87
Manufacturing Expenses	0	0.14	0.18	0.35	0.53
Personnel Expenses	21.08	18.72	22.96	35.64	101.89
Selling Expenses	0	2.34	1.94	6.10	7.46
Administrative Expenses	40.78	40.83	44.89	69.88	84.75
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	260.23	264.85	269.81	313.66	372.76
Operating Profit	94.10	91.42	65.26	65.08	27.11
Other Recurring Income	38.77	41.96	61.68	58.11	33.19
Adjusted PBDIT	132.87	133.38	126.94	123.19	60.30
Financial Expenses	1.26	0.77	1.49	1.75	4.83
Depreciation	1.95	2.19	2.61	6.06	9.65
Other Write offs	0	0	0	0	0
Adjusted PBT	129.66	130.42	122.84	115.38	45.82
Tax Charges	36.48	29.52	37.65	12.02	-0.10
Adjusted PAT	93.18	100.90	85.19	103.36	45.92
Non Recurring Items	0	0.97	1.21	3.11	-41.45
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	93.18	100.90	85.19	103.36	-3.72
Equity Dividend	0	61.73	117.28	24.69	24.69
Preference Dividend	0	0	0	0	0
Retained Earnings	93.18	768.98	728.84	759.72	677.94

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article